Trials / Completed
CompletedNCT00594035
Study to Evaluate Safety and Effectiveness of Spinal Sealant
A Prospective, Multi-Center, Randomized Controlled Study to Compare the Spinal Sealant System as an Adjunct to Sutured Dural Repair With Standard of Care Methods During Spinal Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 158 (actual)
- Sponsor
- Integra LifeSciences Corporation · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of the Spinal Sealant as an adjunct to sutured dural repair compared with standard of care methods (control) to obtain watertight dural closure in patients undergoing spinal surgery.
Detailed description
Neurosurgical procedures in the spine often involve incision of the dura mater to access the spinal cord. If the dural incision is not properly repaired and watertight closure is not achieved cerebrospinal fluid (CSF) can escape presenting a risk for significant morbidity. The most frequent complication of CSF leak is recurring headache complicated with symptoms of nausea and vomiting. Furthermore fluid collection under skin prevents proper wound healing and may lead to wound breakdown and infection of the incision or both. Persistent CSF leak has also been associated with the development of cerebellar hemorrhage and subdural hematoma. Primary repair and watertight closure are paramount to minimizing risk and sequelae associated with CSF leak.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Spinal Sealant System | |
| DEVICE | Standard of care | Standard of care: devices intended to provide a watertight closure |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2008-02-01
- Completion
- 2008-04-01
- First posted
- 2008-01-15
- Last updated
- 2017-09-07
- Results posted
- 2009-12-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00594035. Inclusion in this directory is not an endorsement.